Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Anpario flags stronger-than-expected full-year results

(Sharecast News) - Animal feed additive manufacturer Anpario flagged a stronger-than-expected operating performance for the year ended 31 December on Friday. The AIM-traded company said it anticipated revenue of £37.5m, a significant increase from £31m in 2023, driven by robust sales in the second half of the year.

Adjusted EBITDA was also expected to exceed current market expectations, bolstered by operational efficiencies and favourable year-end foreign exchange movements.

The acquisition of Bio-Vet in September contributed positively, with a strong final quarter performance fueled by heightened demand for products supporting dairy cow health during an avian influenza outbreak.

Additionally, the Middle East and Africa segment delivered exceptional sales growth during the year.

Anpario said it maintained a solid financial position, with year-end cash balances of £10.5m, despite the $6.3m cash acquisition of Bio-Vet and associated assets.

The firm said it planned to leverage its strong balance sheet to invest in innovative natural solutions, expand its global footprint, and explore complementary acquisitions.

Anpario said it would publish its final results for 2024 on or around 26 March.

At 1533 GMT, shares in Anpario were up 10.41% at 405.76p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Sabien Technology inks invoice facility with chairman's firm
(Sharecast News) - Sabien Technology Group announced on Monday that it would enter into an invoice factoring facility with Parris Group, the family office of its executive chairman Richard Parris, to provide additional working capital as it expanded sales of its M2G Cloud Connect service.
CleanTech reports 17pc increase in Laguna Verde resource estimate
(Sharecast News) - CleanTech Lithium reported a 17% increase in the mineral resource estimate for its Laguna Verde project in Chile on Monday, following the acquisition of additional licences, positioning the asset among the country's key lithium developments earmarked for accelerated private-sector advancement.
Abingdon Health secures $2m contract with US-based client
(Sharecast News) - Abingdon Health announced on Monday that it has secured a contract worth about $2m to develop and scale up a new multiplex lateral flow diagnostic test for a US-based client.
Metsera agrees $10bn takeover by Pfizer, shares slide
(Sharecast News) - US biotech firm Metsera tumbled on Monday after it agreed to be bought by Pfizer in a sweetened $10bn deal, with Denmark's Novo Nordisk refraining from making an increased offer.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.